EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Purine and purinergic receptors in health and disease

Yanling Ai, Hengyi Wang, Lu Liu, Yulin Qi, Shiyun Tang, Jianyuan Tang, Nianzhi Chen iD

MedComm · 2023-10 · 4 (5)

DOI: 10.1002/mco2.359 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 07.09.2023. Verfasst von Yanling Ai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology Hospital of Chengdu University of Traditional Chinese Medicine Chengdu China. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purines and purinergic receptors are widely distributed throughout the human body. Purine molecules within cells play crucial roles in regulating energy metabolism and other cellular processes, while extracellular purines transmit signals through specific purinergic receptors. The ubiquitous purinergic signaling maintains normal neural excitability, digestion and absorption, respiratory movement, and other complex physiological activities, and participates in cell proliferation, differentiation, migration, and death. Pathological dysregulation of purinergic signaling can result in the development of various diseases, including neurodegeneration, inflammatory reactions, and malignant tumors. The dysregulation or dysfunction of purines and purinergic receptors has been demonstrated to be closely associated with tumor progression. Compared with other subtypes of purinergic receptors, the P2X7 receptor (P2X7R) exhibits distinct characteristics (i.e., a low affinity for ATP, dual functionality upon activation, the mediation of ion channels, and nonselective pores formation) and is considered a promising target for antitumor therapy, particularly in patients with poor response to immunotherapy This review summarizes the physiological and pathological significance of purinergic signaling and purinergic receptors, analyzes their complex relationship with tumors, and proposes potential antitumor immunotherapy strategies from tumor P2X7R inhibition, tumor P2X7R overactivation, and host P2X7R activation. This review provides a reference for clinical immunotherapy and mechanism investigation.

Schlagwörter

Stichwörter der Autor:innen

ATPP2x7cancerimmunitypurinergictumor microenvironment

Autor:innen und Institutionen

  • Department of Oncology Hospital of Chengdu University of Traditional Chinese Medicine Chengdu China.
  • Department of Infectious Diseases Hospital of Chengdu University of Traditional Chinese Medicine Chengdu China.
  • School of Pharmacy Chengdu University of Traditional Chinese Medicine Chengdu China.
  • Department of Ophthalmology The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou University of Chinese Medicine Guangzhou China.
  • Postdoctoral Research Station of Guangzhou University of Chinese Medicine Guangzhou China.
  • Hospital of Chengdu University of Traditional Chinese Medicine Chengdu China.

ORCID-Profile: Nianzhi Chen

Zitieren

APA

Ai, Y., Wang, H., Liu, L., Qi, Y., Tang, S., Tang, J., & Chen, N. (2023). Purine and purinergic receptors in health and disease. MedComm, 4(5). https://doi.org/10.1002/mco2.359

Vancouver

Ai Y, Wang H, Liu L, Qi Y, Tang S, Tang J, et al. Purine and purinergic receptors in health and disease. MedComm. 2023;4(5). doi:10.1002/mco2.359

BibTeX
@article{Ai2023,
  author = {Ai, Yanling and Wang, Hengyi and Liu, Lu and Qi, Yulin and Tang, Shiyun and Tang, Jianyuan and Chen, Nianzhi},
  title = {Purine and purinergic receptors in health and disease},
  journal = {MedComm},
  year = {2023},
  volume = {4},
  number = {5},
  doi = {10.1002/mco2.359}
}
Kostenlos starten →